Progeria interventions: Difference between revisions

	Progeria Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Progeria from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Progeria interventions On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Progeria interventions All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Progeria interventions
CDC on Progeria interventions
Progeria interventions in the news
Blogs on Progeria interventions
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Progeria interventions

Latest revision as of 02:15, 14 August 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

There are no recommended therapeutic interventions for the management of Hutchinson-Gilford progeria syndrome.

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Xyz}}
+{{Progeria}}
-{{CMG}};
+{{CMG}}; {{AE}} {{VKG}}
 ==Overview==
-There are no recommended therapeutic interventions for the management of [disease name].
+There are no recommended [[therapeutic]] interventions for the management of [[Hutchinson-Gilford progeria syndrome]].
-OR
-[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
-OR
-The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
-OR
-The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
-OR
-[Name of intervention] is the mainstay of treatment for [disease or malignancy].
-==Indications==
-The mainstay of treatment for TT is medical therapy.
 ==References==
@@ Line 31: / Line 11: @@
 {{WH}}
 {{WS}}
-[[Category: (name of the system)]]
+[[Category:Rare disease]]